Adapted Physical Activity Effect and Fatigue in Patients With Breast Cancer
SAPA
1 other identifier
observational
44
1 country
1
Brief Summary
Physical exercise has been identified as a major item of many chronic diseases and cancer rehabilitation. Therefore, physical activity for health is a valid and relevant way to improve quality of life and to manage cancer patient fatigue. The aim of the study is the assessment of the effects of a physical activity retraining program on aerobic capacity, strength and fatigue, in a breast cancer population treated by adjuvant chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2011
CompletedFirst Posted
Study publicly available on registry
March 24, 2011
CompletedStudy Start
First participant enrolled
May 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedAugust 21, 2018
March 1, 2011
2 years
March 23, 2011
August 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
main criterion is exercise tolerance at 27 weeks, measured by VO2 max, following a physical activity (PA) programme
27 weeks
Secondary Outcomes (1)
Assessment at 27 and 54 weeks between the 2 groups of muscle function.
54 weeks
Study Arms (2)
Arm A : physical activity program
Arm A : physical activity program (aerobic and strength training) during the 27 weeks of treatment (chemotherapy and radiotherapy) and conventional follow-up during 27 weeks
Arm B : conventional management
Arm B : conventional management during and after treatment
Eligibility Criteria
adjuvant breast cancer
You may qualify if:
- females between 18 and 75 years of age
- signed written informed consent
- willing to take part in the trial and to follow the instructions
- breast tumour, histologically documented
- patients who have undergone curative surgery
- patients for whom a 6-treatment course of adjuvant chemotherapy (3FEC100 + taxanes) and radiotherapy has been scheduled
- patients with HER2-negative cancer.
You may not qualify if:
- metastatic cancer
- other primary tumours
- disability preventing a proper understanding of the instructions for the trial
- chemotherapy strictly contra-indicated
- patients who are subject to a court protection, wardship or guardianship order
- uncontrolled hypertension
- family history of sudden death in a first-degree relative
- unstabilised heart disease
- current treatment with beta-blockers
- chronic or acute pulmonary disease associated with dyspnoea upon moderate effort
- uncontrolled thyroid dysfunction
- uncontrolled diabetes
- any other serious conditions that are unstabilised, disabling or in which physical exercise is contra-indicated
- unable to attend for follow-up throughout the duration of the study
- ventricular ejection fraction (vef) \< 50%, pregnancy or suckling.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Limoges University Hospital
Limoges, 87042, France
Related Publications (1)
Cornette T, Vincent F, Mandigout S, Antonini MT, Leobon S, Labrunie A, Venat L, Lavau-Denes S, Tubiana-Mathieu N. Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (SAPA): a randomized controlled trial. Eur J Phys Rehabil Med. 2016 Apr;52(2):223-32. Epub 2015 May 19.
PMID: 25986222RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vincent FRANCOIS, MD
University Hospital, Limoges
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 23, 2011
First Posted
March 24, 2011
Study Start
May 1, 2011
Primary Completion
May 1, 2013
Study Completion
July 1, 2013
Last Updated
August 21, 2018
Record last verified: 2011-03